Home » Topics » Conferences

Conferences
RSS

Conformationally restricted CRF1 antagonists developed at Merck & Co.

March 24, 1999

Antiarrhythmic efficacy of Na+/Ca2+ exchange inhibitor demonstrated in preclinical models

March 24, 1999

Pharmacokinetics of AMP-579 are affected by body weight but not by renal function

March 24, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

Allos presents phase Ib results of RSR-13 in patients with angina

March 24, 1999

Dual dopamine D1/D5 antagonist blocks the rewarding effects of cocaine in humans

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Favorable safety and PK/PD profiles reported for CFC-222

March 24, 1999

Kyowa Hakko and Cor select development candidates for inhibiting PDGF receptor phosphorylation

March 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...